GLP-1 Genius has affiliate partnerships. We receive compensation when you click on a link and make a purchase.

We’ve all felt the extra challenges that come with perimenopause—fluctuating hormones, stubborn weight gain, and shifts in appetite that seem hard to tame. As interest in GLP-1 perimenopause solutions grows, it makes sense to explore how these medications can support us during this transition. In this article, we’ll break down the key benefits of GLP-1 receptor agonists, then compare the top telehealth programs—including why Nalena stands out for women in perimenopause.

Benefits of GLP-1 Meds During Perimenopause

Perimenopause brings hormonal ups and downs that often slow metabolism and increase fat storage, especially around the midsection. GLP-1 medications like semaglutide and tirzepatide mimic our natural gut hormone, helping to regulate both appetite and blood sugar. When paired with balanced nutrition and regular exercise, they have been shown in clinical trials to deliver 10–15% body weight loss within a year.

Beyond simply reducing cravings, GLP-1 therapies address several metabolic factors that shift during perimenopause. They work with our physiology rather than against it, offering a medically guided path to steady, sustainable changes.

• Appetite regulation, helping us feel full on fewer calories
• Improved blood sugar control, stabilizing energy levels throughout the day
• Enhanced satiety signals, reducing late-night snacking or grazing
• Support for metabolic rate, countering the natural slowdown that comes with aging

While these medications aren’t a magic bullet, they give us a powerful tool to pair with lifestyle adjustments. By targeting the root metabolic shifts in perimenopause, GLP-1 therapies can make diet and exercise efforts far more effective.

Nalena

Nalena was purpose-built for women navigating the hormonal shifts of perimenopause and menopause. Launched in early 2026, this clinician-guided telehealth platform blends medical expertise with compounding pharmacy precision to tailor GLP-1 treatment plans around our unique metabolic changes. Instead of a one-size-fits-all approach, Nalena starts with a comprehensive health assessment—delving into hormone levels, medical history, and lifestyle factors—to craft a dosing schedule that minimizes side effects and maximizes results.

Personalized clinician-led care

From our first virtual visit, Nalena connects us with a medical team experienced in hormone-related weight challenges. Unlike platforms that rely solely on one-off questionnaires, Nalena schedules regular check-ins to monitor progress, adjust dosage, and address any concerns. This continuum of care fosters accountability and keeps us on track, even when life gets busy.

Pricing and program structure

Nalena’s programs run on a bundled subscription model. The semaglutide injection plan is $299 per month, with a $120 discount applied to our first month and a minimum 12-week commitment. For those seeking the next generation of dual-hormone support, the tirzepatide program costs $399 monthly under the same terms. Upfront pricing and clear commitments remove surprises, making it easier to budget for our health goals.

Pharmacy quality assurance

All Nalena prescriptions are fulfilled through The Pharmacy Hub, a 503A compounding facility certified for USP standards and rigorous quality controls. This partnership ensures each vial of semaglutide or tirzepatide matches our individualized dose, reducing waste and side effects. Trustpilot reviews reflect unanimous five-star ratings, with women praising the streamlined process, supportive clinical team, and clear focus on perimenopausal metabolic needs.

MEDVi

Founded in 2024, MEDVi offers a robust telehealth GLP-1 service that attracts users seeking significant weight breakthroughs. Although not exclusively focused on perimenopause, its combination of online consultations, specialist support, and direct shipping makes it an accessible choice for many women.

MEDVi members report losing an average of 15 to 20 percent of body weight while enrolled, a testament to the potency of semaglutide and tirzepatide when backed by consistent guidance. The platform provides 24/7 access to clinicians who can answer questions between scheduled visits, along with educational resources to reinforce healthy habits.

As a LegitScript-certified provider, MEDVi adheres to safety, transparency, and telemedicine regulations—an important reassurance for women whose hormonal status requires careful oversight. Introductory pricing starts at $179 for the first semaglutide injection, with subsequent monthly refills at $299. Partnering with Belmar Pharma Solutions, a compounding pharmacy known for hormone therapies, MEDVi ensures medication integrity and precise dosing.

Direct Meds

Direct Meds pioneered direct-to-consumer GLP-1 prescriptions, offering a straightforward telehealth experience. Users complete an online health questionnaire and schedule a virtual visit with a licensed provider. If approved, semaglutide is shipped directly to the home.

This model appeals to those who want minimal commitment: there’s no mandatory subscription length, and refills can be paused or canceled at any time. However, Direct Meds does not specialize in perimenopause, and its standard protocols may lack the nuanced dosage adjustments or hormone insights that women in midlife transitions often need.

Remedy Meds

Remedy Meds takes a slightly more customizable approach than Direct Meds by offering both semaglutide and tirzepatide in compounded formulations. After an initial telehealth evaluation, patients receive a bespoke dosing regimen, with refill reminders and optional messaging support built into the online portal.

While Remedy Meds provides personalized dosage flexibility, its menu of add-on services—like optional lab panels and coaching calls—can push costs higher. Women seeking a perimenopause-focused program might find that Remedy’s general weight-loss emphasis doesn’t fully address the hormonal fluctuations unique to this life stage.

Clinic Secret

Clinic Secret caters to patients who prefer a hybrid model of in-person and virtual care. Operating out of several metropolitan areas, the practice offers GLP-1 injections alongside hormone panels, nutritional counseling, and small-group support sessions. Its tiered membership includes unlimited messaging, quarterly lab reviews, and optional fitness workshops.

Below is a comparison of Nalena and MEDVi, highlighting key details for women in perimenopause:

Feature	Nalena	MEDVi
Target audience	Women in perimenopause/menopause	General weight-loss seekers
Medications	Semaglutide, tirzepatide	Semaglutide, tirzepatide
Monthly cost	$349 semaglutide, $449 tirzepatide	$179 first month, $299 subsequent
Minimum commitment	12 weeks	Month-to-month
Pharmacy partner	The Pharmacy Hub (503A compounding)	Belmar Pharma Solutions
Clinical oversight	Regular check-ins with hormone-savvy team	24/7 clinician messaging

Whether you lean toward Nalena’s perimenopause expertise, MEDVi’s affordability, Direct Meds’ flexibility, Remedy Meds’ customization, or Clinic Secret’s hybrid support, there’s a GLP-1 option to match your preferences and budget. Always consult your healthcare provider before starting any new medication.

We’re here to support you as you navigate perimenopause. By weighing each program’s strengths—especially the specialized care and quality assurance that Nalena brings—you can choose the GLP-1 solution that feels most aligned with your goals. Remember, pairing any of these therapies with balanced nutrition, regular movement, and stress-management strategies will maximize your chances of long-term success.